Literature DB >> 3614380

Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering.

S Roberts, J C Cheetham, A R Rees.   

Abstract

A detailed description of the interactions between an antibody and its epitope is necessary to allow an understanding of the way in which antibodies bind to antigenic surfaces presented by foreign molecules. Ideally this should be done by analysis of crystal structures of antibody-antigen complexes, but so far only two of these are available. An alternative strategy combines molecular modelling with site-directed mutagenesis (SDM) and using this we have generated a preliminary model of the complex between Gloop2, an antibody raised against a peptide containing the 'loop' determinant of hen egg-white lysozyme (HEL) which also binds the native protein, and its epitope on the protein surface. The main predictions from our model were; (1) that the surface of interaction between the antibody and the antigen is large (20 A X 15 A) and involves all the complementarity-determining regions (CDRs), (2) that electrostatic interactions were important in the formation of the complex, and (3) that conformational changes in either the loop or in the CDRs may occur during the formation of the complex. Here we report SDM studies which test some of these predictions; removal of two charged residues at the periphery of the combining site increases the affinity of the antibody for its antigen over 8-fold and decreases its ability to cross-react with closely-related antigens. This result is at variance with our original prediction but can be accommodated within our newly refined model; the role of electrostatics in antigen-antibody interactions is now questionable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3614380     DOI: 10.1038/328731a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

1.  Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.

Authors:  J Xiang; Z Chen
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  Antigen mobility in the combining site of an anti-peptide antibody.

Authors:  J C Cheetham; D P Raleigh; R E Griest; C Redfield; C M Dobson; A R Rees
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Modeling antibody hypervariable loops: a combined algorithm.

Authors:  A C Martin; J C Cheetham; A R Rees
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.

Authors:  B M Mueller; R A Reisfeld; S D Gillies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Protein evolution on rugged landscapes.

Authors:  C A Macken; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 6.  The biotechnology and applications of antibody engineering.

Authors:  R Rapley
Journal:  Mol Biotechnol       Date:  1995-04       Impact factor: 2.695

7.  Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold.

Authors:  J Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Stacking and energetic contribution of aromatic islands at the binding interface of antibody proteins.

Authors:  Di Wu; Jing Sun; Tianlei Xu; Shuning Wang; Guoqing Li; Yixue Li; Zhiwei Cao
Journal:  Immunome Res       Date:  2010-09-27

9.  Nucleotide sequence analysis of CDR3 elements of a panel of anti-peptide monoclonal antibodies recognizing parathyroid hormone-related protein.

Authors:  R Rapley; P S Flora; D J Walsh; M R Walker
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

10.  Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.

Authors:  X M He; F Rüker; E Casale; D C Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.